Serological evaluation of Escherichia coli-expressed human T-cell leukemia virus type I env, gag p24, and tax proteins. 1990

S R Coates, and A J Harris, and D L Parkes, and C M Smith, and H L Liu, and R W Akita, and M M Ferrer, and E K Sampson, and J W Brandis, and M X Sliwkowski
Triton Biosciences Inc., Alameda, California 94501.

Three proteins (env, gag, and tax) encoded by the human T-cell leukemia virus type I (HTLV-I) genome were cloned and expressed in Escherichia coli. The env protein contained a substantial part of the gp46 domain and a majority of the p21e domain. The gag protein contained all of p24 and portions of p19 and p15. In addition to these two structural proteins, a full-length tax (p40X) construct was obtained. All three recombinant proteins were purified to near homogeneity. When used in an immunoblot assay, the three recombinant proteins detected antibodies in more HTLV-I antibody-positive patient sera than did the corresponding native proteins. Antibodies to at least two of these three different gene products were detected in 98.4% of adult T-cell leukemia patients, 100% of HTLV-I-associated myelopathy patients, 97.4% of asymptomatic carriers, and 94% of uncharacterized HTLV-I-positive patients. Antibody to recombinant tax was found in 4.9% of adult T-cell leukemia patients, whereas antibody to recombinant env could not be detected. These recombinant proteins from three different gene products may be useful in detecting or confirming the presence of antibodies to HTLV-I.

UI MeSH Term Description Entries
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D006579 Heterozygote An individual having different alleles at one or more loci regarding a specific character. Carriers, Genetic,Genetic Carriers,Carrier, Genetic,Genetic Carrier,Heterozygotes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000956 Antigens, Viral Substances elaborated by viruses that have antigenic activity. Viral Antigen,Viral Antigens,Antigen, Viral
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D015368 Human T-lymphotropic virus 1 A strain of PRIMATE T-LYMPHOTROPIC VIRUS 1 isolated from mature T4 cells in patients with T-lymphoproliferation malignancies. It causes adult T-cell leukemia (LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED), T-cell lymphoma (LYMPHOMA, T-CELL), and is involved in mycosis fungoides, SEZARY SYNDROME and tropical spastic paraparesis (PARAPARESIS, TROPICAL SPASTIC). ATLV,Adult T-Cell Leukemia-Lymphoma Virus I,HTLV-1,HTLV-I,Human T-Cell Leukemia Virus I,Leukemia Virus I, Human T-Cell,T-Cell Leukemia Virus I, Human,Adult T Cell Leukemia Lymphoma Virus I,Human T Cell Leukemia Virus I,Leukemia Lymphoma Virus I, Adult T Cell,Leukemia Virus I, Human T Cell,T Cell Leukemia Virus I, Human,Human T lymphotropic virus 1

Related Publications

S R Coates, and A J Harris, and D L Parkes, and C M Smith, and H L Liu, and R W Akita, and M M Ferrer, and E K Sampson, and J W Brandis, and M X Sliwkowski
January 1998, Arthritis and rheumatism,
S R Coates, and A J Harris, and D L Parkes, and C M Smith, and H L Liu, and R W Akita, and M M Ferrer, and E K Sampson, and J W Brandis, and M X Sliwkowski
January 1999, European journal of biochemistry,
S R Coates, and A J Harris, and D L Parkes, and C M Smith, and H L Liu, and R W Akita, and M M Ferrer, and E K Sampson, and J W Brandis, and M X Sliwkowski
January 1989, Journal of cancer research and clinical oncology,
S R Coates, and A J Harris, and D L Parkes, and C M Smith, and H L Liu, and R W Akita, and M M Ferrer, and E K Sampson, and J W Brandis, and M X Sliwkowski
January 1985, Gene,
S R Coates, and A J Harris, and D L Parkes, and C M Smith, and H L Liu, and R W Akita, and M M Ferrer, and E K Sampson, and J W Brandis, and M X Sliwkowski
November 1988, Japanese journal of cancer research : Gann,
S R Coates, and A J Harris, and D L Parkes, and C M Smith, and H L Liu, and R W Akita, and M M Ferrer, and E K Sampson, and J W Brandis, and M X Sliwkowski
December 1991, Biochemical and biophysical research communications,
S R Coates, and A J Harris, and D L Parkes, and C M Smith, and H L Liu, and R W Akita, and M M Ferrer, and E K Sampson, and J W Brandis, and M X Sliwkowski
January 1991, Voprosy virusologii,
S R Coates, and A J Harris, and D L Parkes, and C M Smith, and H L Liu, and R W Akita, and M M Ferrer, and E K Sampson, and J W Brandis, and M X Sliwkowski
July 1984, Virology,
S R Coates, and A J Harris, and D L Parkes, and C M Smith, and H L Liu, and R W Akita, and M M Ferrer, and E K Sampson, and J W Brandis, and M X Sliwkowski
December 1985, Japanese journal of cancer research : Gann,
S R Coates, and A J Harris, and D L Parkes, and C M Smith, and H L Liu, and R W Akita, and M M Ferrer, and E K Sampson, and J W Brandis, and M X Sliwkowski
January 1993, Molekuliarnaia genetika, mikrobiologiia i virusologiia,
Copied contents to your clipboard!